Ileal Conduit vs Neobladder After Radical Cystectomy: Which Is Right for You?

For patients undergoing radical cystectomy for bladder cancer, one of the most important questions is:

“If my bladder is removed, how will I pass urine afterwards?”

Removing the bladder is only one part of radical cystectomy. Because the kidneys continue to produce urine, the surgeon must create a new pathway to store or drain urine. This is called a urinary diversion. The principal options include an ileal conduit, an orthotopic neobladder, and, in selected circumstances, a continent cutaneous diversion.

There is no single urinary diversion that is best for every patient. The appropriate choice depends on the cancer, kidney function, general health, anatomy, lifestyle and—importantly—the patient's expectations.

What Is Urinary Diversion After Bladder Removal?

During radical cystectomy, the urinary bladder is removed as part of the treatment for bladder cancer. The ureters—the tubes carrying urine from the kidneys—therefore need to be connected to a new urinary drainage system.

Segments of intestine are commonly used to construct this new pathway.

The two options most frequently discussed are:

Ileal conduit: urine drains continuously through a stoma into an external collection bag.

Orthotopic neobladder: a new internal reservoir is constructed from intestine and connected to the urethra, allowing urine to be passed through the natural urinary passage.

Both are established forms of urinary diversion after radical cystectomy.

What Is an Ileal Conduit?

An ileal conduit is the most commonly used urinary diversion after radical cystectomy.

A short segment of small intestine—the ileum—is isolated while maintaining its blood supply. The remaining intestine is reconnected so that digestion continues normally.

The ureters are connected to this isolated intestinal segment, and its other end is brought through the abdominal wall to create a stoma.

Urine then follows the pathway:

Kidneys → Ureters → Ileal conduit → Stoma → External urostomy bag

Urine drains continuously because an ileal conduit does not function as a storage reservoir.

Will I Have to Wear a Bag Permanently?

Yes.

With an ileal conduit, urine drains through the abdominal stoma into a urostomy appliance attached to the skin.

Modern appliances are designed to remain securely attached beneath clothing and can be emptied periodically during the day.

Learning appropriate stoma and appliance care is an important part of recovery after surgery.

What Are the Advantages of an Ileal Conduit?

An ileal conduit is a well-established and generally reliable form of urinary diversion.

Compared with continent reconstruction, it avoids the need to create a large internal urinary reservoir and does not require the patient to learn how to empty a neobladder.

It may therefore be particularly appropriate when a neobladder is unsuitable because of the patient's cancer, renal function, bowel availability, functional status or ability to manage a continent diversion.

The trade-off is the need for a permanent abdominal stoma and external appliance.

What Is an Orthotopic Neobladder?

A neobladder attempts to recreate an internal urinary reservoir after the original bladder has been removed.

A segment of intestine is reconstructed into a low-pressure reservoir and connected to the urethra.

Urine then follows:

Kidneys → Ureters → Neobladder → Urethra

This allows appropriately selected patients to continue passing urine through the natural urinary passage rather than through an abdominal stoma.

However, a neobladder does not function exactly like the original bladder.

This distinction is important when counselling patients.

How Do You Pass Urine With a Neobladder?

A normal bladder has specialised muscle and neurological mechanisms that help generate the sensation of fullness and coordinate urination.

A neobladder is constructed from intestine and therefore behaves differently.

Patients need to learn a new method of emptying the reservoir. This usually involves timed voiding, relaxation of the pelvic floor and increasing abdominal pressure rather than relying on normal bladder contraction.

Initially, patients generally empty their neobladder according to a schedule while its capacity gradually increases.

Some patients may have incomplete emptying and require clean intermittent self-catheterisation. The possibility of needing catheterisation should therefore be discussed before choosing a neobladder. The AUA guideline specifically emphasises the patient's ability and willingness to catheterise when considering continent urinary diversion.

Will I Be Continent With a Neobladder?

Many appropriately selected patients achieve useful daytime urinary control after rehabilitation, but a neobladder should not be presented as guaranteeing normal continence.

Urinary leakage can occur, particularly during the initial recovery period.

Night-time leakage can be more troublesome than daytime leakage, and patients may need to wake periodically to empty their neobladder.

Continence typically improves with time, training and pelvic-floor rehabilitation, but outcomes vary between individuals.

This should be discussed realistically before surgery.

Who Is Suitable for a Neobladder?

Not every patient undergoing radical cystectomy should receive a neobladder.

Several factors need to be considered.

Cancer-related factors

The urethra needs to be oncologically suitable for preservation because the neobladder will be connected to it.

AUA guidance specifically recommends confirming a negative urethral margin when performing an orthotopic urinary diversion.

Kidney and liver function

Urine remains in prolonged contact with intestinal tissue in a continent reservoir. This can produce metabolic consequences because the intestine absorbs substances from the urine.

Significant renal or hepatic dysfunction can therefore make a continent diversion inappropriate.

Ability to manage the neobladder

A patient needs to understand and participate in:

• timed voiding;
• neobladder training;
• monitoring residual urine when required;
• pelvic-floor rehabilitation; and
• intermittent self-catheterisation if adequate emptying cannot be achieved.

Physical and cognitive ability to perform these tasks therefore matters.

Bowel-related factors

Because intestinal tissue is required for reconstruction, previous bowel surgery, bowel disease or insufficient suitable bowel can influence the choice of diversion.

Is Age a Contraindication to Neobladder?

Age alone should not be the sole deciding factor.

A patient's physiological fitness, kidney function, cognitive and manual ability, cancer characteristics and capacity to manage the neobladder are generally more meaningful than chronological age alone.

An older but otherwise fit and motivated patient may potentially be considered for continent diversion, while a younger patient with significant renal impairment or other contraindications may not be suitable.

The decision should therefore be individualised.

Ileal Conduit vs Neobladder: Which Gives Better Quality of Life?

This is one of the most frequently asked questions—and the answer is more nuanced than many patients expect.

It may seem intuitive that avoiding an external bag must automatically provide better quality of life. However, studies comparing quality of life after different urinary diversions have produced variable results.

The AUA guideline notes that although some studies report better or marginally better quality-of-life outcomes with neobladders, many studies show similar satisfaction among appropriately counselled patients regardless of diversion type.

This is an important point.

A successful outcome is not simply:

“No bag = better.”

A neobladder has its own demands, including continence training, night-time emptying and the possibility of intermittent catheterisation.

Conversely, an ileal conduit requires adaptation to a stoma and external appliance but can provide a predictable and reliable method of urinary drainage.

The most appropriate diversion is therefore the one that best matches the patient's medical suitability, priorities and expectations.

Does an Ileal Conduit Mean a Poorer Lifestyle?

Not necessarily.

After appropriate recovery and adaptation, many patients with an ileal conduit return to routine activities.

Living successfully with a stoma involves learning:

• how to empty and change the appliance;
• appropriate skin care around the stoma;
• how to recognise problems with the stoma;
• management of the appliance during sleep and travel; and
• when to contact the clinical team.

Preoperative counselling with appropriate stoma-site marking and postoperative stoma education can make this transition considerably easier.

What Are the Long-Term Issues After Urinary Diversion?

Whichever diversion is chosen, follow-up does not end once the patient has recovered from surgery.

Long-term assessment may include monitoring:

Kidney function: obstruction, infection and changes in the upper urinary tract can occur.

Electrolytes and metabolic abnormalities: intestinal urinary reservoirs can alter electrolyte and acid-base balance.

Vitamin B12: depending upon the length and location of ileum used, long-term monitoring may be appropriate.

Urinary infections: these need to be assessed according to symptoms and the individual diversion.

Stoma-related problems: patients with an ileal conduit may develop skin, appliance or stomal issues.

Neobladder function: continence, capacity and adequacy of emptying need ongoing assessment.

Patients also require continued cancer surveillance after radical cystectomy.

Can a Neobladder Be Made During Robotic Radical Cystectomy?

Yes.

Urinary diversion can be constructed following either open or robot-assisted radical cystectomy.

With robotic radical cystectomy, reconstruction may be performed using intracorporeal techniques, in which the urinary diversion is constructed within the abdomen robotically, depending upon surgeon expertise and the individual clinical situation.

However, the availability of robotic surgery should not determine the choice of urinary diversion.

The sequence of decision-making should be:

Is radical cystectomy appropriate? → Which urinary diversion is most appropriate? → Which surgical approach is appropriate for this patient?

Technology should support the cancer treatment plan rather than dictate it.

How Do I Choose Between an Ileal Conduit and Neobladder?

This decision should ideally be made before radical cystectomy, after detailed discussion with the operating surgeon.

A useful consultation should address questions such as:

Is a neobladder oncologically safe for me?

Are my kidneys suitable for a continent diversion?

Am I comfortable living with a stoma and external appliance?

Am I willing to accept possible night-time leakage with a neobladder?

Would I be able and willing to perform intermittent self-catheterisation if required?

How will either option affect my lifestyle?

What is my surgeon's experience with each type of reconstruction?

Current AUA guidance recommends discussing ileal conduit, continent cutaneous diversion and orthotopic neobladder with patients undergoing radical cystectomy when they are appropriate candidates.

Urinary Diversion and Radical Cystectomy in Lucknow

For patients considering radical cystectomy for bladder cancer in Lucknow, choosing the urinary diversion is an important part of treatment planning—not an afterthought after deciding to remove the bladder.

At Uro-Onco Connect, patients being evaluated for radical cystectomy are counselled regarding the available urinary diversion options according to their:

cancer characteristics → kidney function → overall fitness → anatomy → lifestyle → personal preferences.

For appropriately selected patients, both ileal conduit and orthotopic neobladder reconstruction can be considered as part of the radical cystectomy pathway.

The objective is not to recommend the most complex reconstruction.

The objective is to select the urinary diversion that provides oncological safety while offering the most appropriate long-term functional outcome for the individual patient.

Dr. Anshuman Singh
M.S., M.Ch. Urology (Gold Medalist)
Fellowship – Uro-Oncology & Robotic Surgery (USI, Intuitive Certified)
Visiting Fellow – Robotic Uro-Oncology (Fundació Puigvert, Spain)
Clinical Observer – Robotic Pelvic Oncology (University College London Hospitals, London)
Vice Chairperson – Uro-Oncology & Robotic Surgery
Chandan Cancer Institute, Chandan Hospital
Lucknow

Dr. Anshuman Singh is a Uro-Oncology and Robotic Surgery specialist in Lucknow with dedicated training in the surgical management of urological cancers. His clinical practice focuses on bladder cancer, prostate cancer, kidney cancer, testicular cancer, penile cancer and other complex urological malignancies, with particular emphasis on uro-oncological and robot-assisted surgery.

Patients who have been advised radical cystectomy can seek a specialist uro-oncology opinion regarding robotic or open radical cystectomy, pelvic lymph-node dissection, ileal conduit, neobladder and other urinary diversion options, as well as the overall treatment pathway for bladder cancer.